Pharsight

Ameluz patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6559183 BIOFRONTERA Nano-emulsion of 5-aminolevulinic acid
Nov, 2019

(4 years ago)

US11540981 BIOFRONTERA Nanoemulsion formulation with improved stability and cell penetration
Feb, 2028

(3 years from now)

US11235169 BIOFRONTERA Illumination device for photodynamic therapy, method for treating a skin disease and method for operating an illumination device
Oct, 2040

(16 years from now)

Ameluz is owned by Biofrontera.

Ameluz contains Aminolevulinic Acid Hydrochloride.

Ameluz has a total of 3 drug patents out of which 1 drug patent has expired.

Expired drug patents of Ameluz are:

  • US6559183

Ameluz was authorised for market use on 10 May, 2016.

Ameluz is available in gel;topical dosage forms.

Ameluz can be used as treatment of actinic keratoses by photodynamic therapy, topical lesion-directed and field-directed treatment of actinic keratosis of the face and scalp with photodynamic therapy by positioning an illumination device in an appropriate distance and illuminating the treatment area with narrowband red light.

The generics of Ameluz are possible to be released after 15 October, 2040.

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) May 10, 2019

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using AMINOLEVULINIC ACID HYDROCHLORIDE ingredient

Market Authorisation Date: 10 May, 2016

Treatment: Treatment of actinic keratoses by photodynamic therapy; Topical lesion-directed and field-directed treatment of actinic keratosis of the face and scalp with photodynamic therapy by positioning an illu...

Dosage: GEL;TOPICAL

More Information on Dosage

AMELUZ family patents

Family Patents